Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK SLAGELSE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   2.1% 1.8% 1.9% 1.8% 3.0% 2.1% 14.3% 14.3%   Credit score (0-100)   69 73 71 70 57 66 15 15   Credit rating   A A A A BBB A BB BB   Credit limit (kDKK)   0.2 1.5 1.0 1.3 0.0 0.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,128 2,398 2,848 3,716 3,765 4,000 0.0 0.0   EBITDA   1,145 1,435 1,601 2,010 303 1,274 0.0 0.0   EBIT   1,100 1,383 1,514 1,917 210 1,210 0.0 0.0   Pre-tax profit (PTP)   1,107.0 1,370.1 1,516.0 1,935.0 240.0 1,217.0 0.0 0.0   Net earnings   863.0 1,068.7 1,182.0 1,509.0 187.0 949.1 0.0 0.0   Pre-tax profit without non-rec. items   1,107 1,370 1,516 1,935 240 1,217 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   114 606 568 475 382 128 0.0 0.0   Shareholders equity total   988 1,194 1,307 1,634 312 1,074 0.0 0.0   Interest-bearing liabilities   152 0.0 0.0 0.0 260 0.0 0.0 0.0   Balance sheet total (assets)   1,571 1,673 1,998 2,392 917 1,734 0.0 0.0   Net Debt   -1,098 -493 -454 -498 -51.0 -519 0.0 0.0     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,128 2,398 2,848 3,716 3,765 4,000 0.0 0.0   Gross profit growth   -1.7% 12.7% 18.8% 30.5% 1.3% 6.2% -100.0% 0.0%   Employees   2 2 3 3 3 3 0 0   Employee growth %   0.0% 0.0% 50.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,571 1,673 1,998 2,392 917 1,734 0 0   Balance sheet change%   5.2% 6.5% 19.4% 19.7% -61.7% 89.1% -100.0% 0.0%   Added value   1,145.0 1,434.6 1,601.0 2,010.0 303.0 1,273.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -72 440 -125 -186 -186 -318 -128 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   51.7% 57.7% 53.2% 51.6% 5.6% 30.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   72.4% 85.2% 82.8% 88.4% 14.6% 91.8% 0.0% 0.0%   ROI %   101.1% 117.2% 118.6% 128.6% 21.2% 143.1% 0.0% 0.0%   ROE %   84.5% 98.0% 94.5% 102.6% 19.2% 136.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   62.9% 71.4% 65.4% 68.3% 34.0% 61.9% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -95.9% -34.3% -28.4% -24.8% -16.8% -40.8% 0.0% 0.0%   Gearing %   15.4% 0.0% 0.0% 0.0% 83.3% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.9% 16.4% 0.0% 0.0% 1.5% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   3.3 2.3 2.1 2.6 0.9 2.4 0.0 0.0   Current Ratio   3.3 2.3 2.1 2.6 0.9 2.4 0.0 0.0   Cash and cash equivalent   1,250.0 492.6 454.0 498.0 311.0 519.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   987.0 574.8 737.0 1,160.0 -73.0 926.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   573 717 534 670 101 425 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   573 717 534 670 101 425 0 0   EBIT / employee   550 691 505 639 70 403 0 0   Net earnings / employee   432 534 394 503 62 316 0 0